Suven Life Sciences Ltd Q1 FY25 consolidated loss at Rs. 28.03 crores

Suven Life Sciences Limited has reported Consolidated financial results for the period ended June 30, 2024.

Financial Results (Q1 FY2025) - QoQ Comparison

The company has reported total income of Rs. 5.0143 crores during the period ended June 30, 2024 as compared to Rs. 6.6683 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs. -28.0397 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. -26.5407 crores for the period ended March 31, 2024.

The company has reported EPS of Rs. -1.29 for the period ended June 30, 2024 as compared to Rs. -1.22 for the period ended March 31, 2024.

Financials	Q1 FY2025	Q4 FY2024	% Change
Total Income	₹ 5.0143 crs	₹6.6683 crs	-24.80%
Net Profit	₹-28.0397 crs	₹-26.5407 crs	5.65%
EPS	₹-1.29	₹-1.22	5.74%

Financial Results (Q1 FY2025) - YoY Comparison

The company has reported total income of Rs. 5.0143 crores during the period ended June 30, 2024 as compared to Rs.9.4369 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs.-28.0397 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.-24.0905 crores for the period ended June 30, 2023.

The company has reported EPS of Rs.-1.29 for the period ended June 30, 2024 as compared to Rs.-1.10 for the period ended June 30, 2023.

Financials	Q1 FY2025	Q1 FY2024	% Change
Total Income	₹ 5.0143 crs	₹9.4369 crs	-46.86%
Net Profit	₹-28.0397 crs	₹-24.0905 crs	16.39%
EPS	₹-1.29	₹-1.10	17.27%

Shares of Suven Life Sciences Limited was last trading in BSE at Rs. 135.25 as compared to the previous close of Rs. 142.35. The total number of shares traded during the day was 39781 in over 946 trades.

The stock hit an intraday high of Rs. 140.80 and intraday low of 135.25. The net turnover during the day was Rs. 5429069.00.

Source : Equity Bulls

Keywords

SuvenLifeSciences Q1FY25 FY2025 Q1FY2025 ResultUpdate